Clinical trial
Post Approval Study of the remedē System
NCT03425188 · Respicardia, Inc., Industry · Completed
Key facts
| NCT number | NCT03425188 |
|---|---|
| Title | Post Approval Study of the remedē System |
| Official title | Post Approval Study of the remedē System |
| Lead sponsor | Respicardia, Inc., Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Central Sleep Apnea |
| Enrollment | 53 |
| Start date | Jun 28, 2018 |
| Primary completion | Aug 4, 2020 |
| Completion | Aug 4, 2020 |
| First posted | Feb 7, 2018 |
| Last update posted | Apr 22, 2021 |
| Countries | Germany, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: